Molecular genetic test system for diagnosis of x-linked agammaglobulinemia

  • M. V. Dybkov
  • Yu. S. Stepanovskyy
  • L. I. Chernyhova
  • A. P. Volokha
  • A. M. Hilfanova
  • A. V. Bondarenko
  • F. I. Lapiy
  • K. M. Dybkova
  • G. D. Telegeev


Aim. Primary immunodeficiencies are disorders in which immune system is missing or does not function normally due to genetic disorders. X-linked agammaglobulinemia (XLA) is a rare genetic disorder in which don’t generate of mature B cells, which manifests as a complete or near-complete lack of proteins called gamma globulins, including antibodies, in their bloodstream. The BTK protein is the key regulator of β-cell maturation, so mutations in the BTK gene lead to hereditary agammaglobulinemia. Detection of mutations of the BTK gene is important for confirmation of the diagnosis in patients with XLA. Methods. DNA and RNA extraction, RT-PCR, direct Sanger sequencing of PCR fragments. Results. An analysis of blood samples from patients with XLA using a proposed test system was performed. It has been shown that the proposed test system allows for the initial screening of mutations in the BTK gene. Conclusions. The test system for the detection of mutations in patients with X-linked agammaglobulinemia, based on using of reverse transcriptase PCR and direct sequencing, was developed and tested on clinical samples. This system is proposed for the initial screening of BTK gene mutations inUkraine.

Keywords: X-linked agammaglobulinemia, XLA, BTK, mutation, RT-PCR, primary immunodeficiency.


# 300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA. OMIM database (ed at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine). URL:

Sideras P., Smith C.I. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol. 1995. Vol. 59. P. 135–223.

Bruton O.C. Agammaglobulinemia. Pediatrics. 1952. Vol. 9. P. 722–728.

RAPID Project (ed by Uktainian Association of Paediatric Immunology & Dept of Paediatric Infectious Diseases and Paediatric Immunology of Shupyk National Medical Academy of Postgraduate Education) URL: (Last accessed: 28.02.2018).

Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M., Smith C.I.E., Bentley D.R. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993. Vol. 361, No. 6409. P. 226–233.

Vorechovsky I., Zhou J.N., Vetrie D., Bentley D., Bjorkander J., Hammarstrom L., Smith C.I.E. Molecular diagnosis of X-linked agammaglobulinaemia. Lancet. 1993. Vol. 341. P. 1153.

* 300300 BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK. OMIM database (ed at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine). URL: (Last accessed: 28.02.2018).

Vihinen M., Vetrie D., Maniar H.S., Ochs H.D., Zhu Q., Vorechovsky I., Webster A.D.B., Notarangelo L.D., Nilsson L., Sowadski J.M., Smith C.I.E. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. Proc Natl Acad Sci USA. 1994. Vol. 91, No. 26. P. 12803–12807.

Rohrer J., Parolini O., Belmont J.W., Conley M.E. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia. Immunogenetics. 1994. Vol. 40, No. 5. P. 319–324.

Hendriks R.W., Bredius R.G., Pike-Overzet K., Staal F.J. Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man. Expert Opin Ther Targets. 2011. Vol. 15, No. 8. P. 1003–1021. doi: 10.1517/14728222.2011.585971.

Shared database BTK (Bruton tyrosine kinase) LOVD v.3.0 Build 20c Curators: G.C.P. Schaafsma and M. Vihinen. URL: (Last accessed: 28.02.2018).

Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 1987. Vol. 162, No. 1. P. 156–159.

Ribaudo R. Preparation of RNA from Tissues and Cells. Current Protocols in Immunology. 2001. UNIT 10.11.1. doi: 10.1002/0471142735.im1011s04.